Absci
Absci is a company utilizing AI and synthetic biology to enhance the therapeutic possibilities of proteins. Our Integrated Drug Creation™ Platform streamlines the process of identifying drug targets, discovering biotherapeutic candidates, and manufacturing them. Biotech and pharma companies collaborate with us to create innovative protein-based drugs, such as Bionic Proteins™ with nonstandard amino acids, that may be difficult to produce using traditional methods. Our aim is to facilitate the development of improved medications by turning concepts into drugs. Visit www.absci.com for additional details.
Absci is a company utilizing AI and synthetic biology to enhance the therapeutic possibilities of proteins. Our Integrated Drug Creation™ Platform streamlines the process of identifying drug targets, discovering biotherapeutic candidates, and manufacturing them. Biotech and pharma companies collaborate with us to create innovative protein-based drugs, such as Bionic Proteins™ with nonstandard amino acids, that may be difficult to produce using traditional methods. Our aim is to facilitate the development of improved medications by turning concepts into drugs. Visit www.absci.com for additional details.
Absci has raised $370M across 5 rounds. Its most recent round was a Series Unknown of $100M in Jun 2026. Full funding history, investors, and team are detailed below.
Funding history
5 rounds on record — latest round shown, the rest unlock with a paid plan.
Unlock 4 earlier rounds — dates, amounts, round types — plus the lead investor for every round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Absci is featured in
Similar companies
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Global Sales Tax Compliance Software
Derya is an AI-native freight-forwarding/logistics software company that provides an AI workbench for freight forwarders and related content.
TIFIN is a platform that conceives, creates, and operates fintech companies in the areas of wealth management, investments, and personal finance. Their operating companies are shaping the future of investor experience with intelligent products that recognize the uniqueness of each investor. TIFIN leverages the combined power of investment intelligence, data science, and technology to make investing a more powerful driver of financial well-being.
8090 Solutions provides an AI-native software development platform through Software Factory, a system designed to help teams manage the software development lifecycle from planning to deployment. The platform connects business requirements, architecture planning, implementation tasks, testing, and feedback within a shared workspace using AI-driven workflows and knowledge management. 8090 Solutions enables organizations to coordinate product, engineering, and business teams while maintaining visibility across software projects. The company’s solutions support custom software development, AI-assisted engineering processes, and enterprise software delivery through structured collaboration between teams and AI agents.
Developers no longer have to manually piece together the impact of pull requests; Baz models, analyzes and reviews code changes, detecting breaking changes, enforcing consistency, and highlighting misaligned coding patterns. Baz makes every review faster, more accurate, and aligned with the real-world impact of the code changes being made.
Eccentric Machines is a manufacturer of robotic actuator technology enabling advanced motion control for embodied AI systems.
EIS Automation provides modular automation and robotic solutions for manufacturing.
Pocket is a technology company that develops an AI-enabled note-taking system combining a dedicated recording device with companion software. Its platform records in-person conversations and phone calls, transcribes audio, and organizes the content into searchable transcripts, summaries, action items, and mind maps. The system supports offline recording, cloud synchronization, and access across mobile, desktop, and web applications, with support for more than 120 languages. Pocket also provides AI-powered features for organizing, searching, and exporting recorded information while offering integrations with task management workflows. Its products are designed for individuals and teams who need to capture, organize, and retrieve information from conversations and spoken ideas.
Straiker builds AI-native security solutions tp protect customers from a spectrum of security & safety risks.
Engine Biosciences is a biotech company that uses machine learning to study genomics for the purpose of drug discovery. They are a technology company based in both San Francisco and Asia that is funded by investors. They specialize in network biomedicine and have developed their own patented technologies that involve extensive laboratory experimentation and artificial intelligence algorithms. These technologies are used for both drug discovery and cellular reprogramming. The company's research and development platform, which was created by a team of esteemed scientists and professors from universities such as MIT and Harvard, significantly speeds up and reduces the cost of developing new medical treatments. Engine Biosciences actively utilizes this platform internally and collaborates with partners in various disease areas.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.